News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
Dubensky Thomas W.
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
01/05/2023 |
4
| Dubensky Thomas W. (President) has filed a Form 4 on Tempest Therapeutics, Inc.
Txns:
| Granted 102,700 options to buy
@ $1.23, valued at
$126.3k
|
|
08/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/19/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
06/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/11/2022 |
4
| Dubensky Thomas W. (President) has filed a Form 4 on Tempest Therapeutics, Inc.
Txns:
| Bought 2,000 shares
@ $4.78, valued at
$9.6k
|
|
01/06/2022 |
4
| Dubensky Thomas W. (President) has filed a Form 4 on Tempest Therapeutics, Inc.
Txns:
| Granted 53,100 options to buy
@ $5.45, valued at
$289.4k
|
|
06/29/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/29/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
08/11/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/06/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
06/14/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
06/05/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
05/15/2017 |
4
| Dubensky Thomas W. (Chief Scientific Officer) has filed a Form 4 on ADURO BIOTECH, INC.
Txns:
| Sold 1,400 shares
@ $9.9071, valued at
$13.9k
Sold 4,299 shares
@ $9.9227, valued at
$42.7k
Exercised 1,400 options to buy
@ $0.52, valued at
$728 Exercised 4,299 options to buy
@ $0.52, valued at
$2.2k
|
|
03/10/2017 |
4
| Dubensky Thomas W. (Chief Scientific Officer) has filed a Form 4 on ADURO BIOTECH, INC.
Txns:
| Sold 25,000 shares
@ $10.9631, valued at
$274.1k
Exercised 14,904 options to buy
@ $0.52, valued at
$7.8k
Exercised 3,165 options to buy
@ $0.52, valued at
$1.6k
Exercised 6,931 options to buy
@ $1.45, valued at
$10k
|
|
01/05/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
12/14/2016 |
4
| Dubensky Thomas W. (Chief Scientific Officer) has filed a Form 4 on ADURO BIOTECH, INC.
Txns:
| Granted 29,800 options to buy
@ $11.15, valued at
$332.3k
|
|
12/05/2016 |
4
| Dubensky Thomas W. (Chief Scientific Officer) has filed a Form 4 on ADURO BIOTECH, INC.
Txns:
| Sold 25,000 shares
@ $10.94, valued at
$273.5k
Exercised 13,863 options to buy
@ $1.45, valued at
$20.1k
Exercised 8,262 options to buy
@ $0.52, valued at
$4.3k
Exercised 2,875 options to buy
@ $0.52, valued at
$1.5k
|
|
11/14/2016 |
4
| Dubensky Thomas W. (Chief Scientific Officer) has filed a Form 4 on ADURO BIOTECH, INC.
Txns:
| Sold 25,000 shares
@ $14.7763, valued at
$369.4k
Exercised 21,062 options to buy
@ $1.45, valued at
$30.5k
Exercised 3,938 options to buy
@ $0.52, valued at
$2k
|
|
10/05/2016 |
4
| Dubensky Thomas W. (Chief Scientific Officer) has filed a Form 4 on ADURO BIOTECH, INC.
Txns:
| Sold 25,000 shares
@ $12.6763, valued at
$316.9k
Exercised 15,524 options to buy
@ $1.45, valued at
$22.5k
Exercised 9,476 options to buy
@ $0.52, valued at
$4.9k
|
|
09/14/2016 |
4
| Dubensky Thomas W. (Chief Scientific Officer) has filed a Form 4 on ADURO BIOTECH, INC.
Txns:
| Granted 39,900 shares
@ $0 |
|
09/02/2016 |
4
| Dubensky Thomas W. (Chief Scientific Officer) has filed a Form 4 on ADURO BIOTECH, INC.
Txns:
| Sold 25,000 shares
@ $14.031, valued at
$350.8k
Exercised 16,407 options to buy
@ $1.45, valued at
$23.8k
Exercised 8,593 options to buy
@ $0.52, valued at
$4.5k
|
|
08/12/2016 |
4
| Dubensky Thomas W. (Chief Scientific Officer) has filed a Form 4 on ADURO BIOTECH, INC.
Txns:
| Sold 25,000 shares
@ $15.18, valued at
$379.5k
Exercised 12,500 options to buy
@ $1.45, valued at
$18.1k
Exercised 12,500 options to buy
@ $0.52, valued at
$6.5k
|
|
07/07/2016 |
4
| Dubensky Thomas W. (Chief Scientific Officer) has filed a Form 4 on ADURO BIOTECH, INC.
Txns:
| Sold 25,000 shares
@ $11.61, valued at
$290.3k
Exercised 13,939 options to buy
@ $1.45, valued at
$20.2k
Exercised 11,061 options to buy
@ $0.52, valued at
$5.8k
|
|
06/10/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
05/18/2016 |
4
| Dubensky Thomas W. (Chief Scientific Officer) has filed a Form 4 on ADURO BIOTECH, INC.
Txns:
| Sold 905 shares
@ $8.2, valued at
$7.4k
|
|
|
|